Projects funded by the NCN
Role of RNase activity of MCPIP1 protein in neuroblastoma suppression.
2017/25/N/NZ1/01254
Keywords:
cancer neuroblastoma inflammation MCPIP1 ribonuclease Akt/mTOR cell cycle
Descriptors:
- NZ1_1: Molecular biology
- NZ3_1: Cell biology
- NZ1_2: Biochemistry
Panel:
NZ1 - Molecular biology, structural biology, biotechnology: molecular biology, structural biology, biotechnology
Host institution :
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 13 - announced on 2017-03-15
Amount awarded: 141 480 PLN
Project start date (Y-m-d): 2018-01-30
Project end date (Y-m-d): 2021-01-29
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- MCPIP1 ribonuclease can bind and cleave AURKA mRNA in MYCN-amplified neuroblastoma cellsAuthors:Iwona Nowak, Elżbieta Boratyn, Sebastian Student, Stephan F Bernhart, Jörg Fallmann, Małgorzata Durbas, Peter F Stadler, Hanna RokitaAcademic press:RNA biology (rok: 2021, tom: 18, strony: 144-156), Wydawca: Taylor and Francis OnlineStatus:PublishedDOI:10.1080/15476286.2020.1804698. - link to the publication